You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1942238 |
---|---|
Category | Small Molecules |
Description | Dihydroquinoline-pyrazoline DQP-997-74 (compound 2i) is a selective N-methyl-d-aspartate receptor (NMDAR) inhibitor that preferentially targets GluN2C/D subunits, with IC50 values of 0.069 μM and 0.035 μM, respectively, and possesses blood-brain barrier permeability. It enhances its inhibitory potency in a time-dependent manner when combined with the agonist glutamate, reducing epileptogenic events in a murine model of tuberous sclerosis complex (TSC)-induced epilepsy. DQP-997-74 is potentially applicable for the study of NMDAR-related neurological diseases [1]. |
Purity | 98.00% |
MW | 570.37 |
Biological Activity | Dihydroquinoline-pyrazoline DQP-997-74 (compound 2i) is a selective N-methyl-d-aspartate receptor (NMDAR) inhibitor that preferentially targets GluN2C/D subunits, with IC50 values of 0.069 μM and 0.035 μM, respectively, and possesses blood-brain barrier permeability. It enhances its inhibitory potency in a time-dependent manner when combined with the agonist glutamate, reducing epileptogenic events in a murine model of tuberous sclerosis complex (TSC)-induced epilepsy. DQP-997-74 is potentially applicable for the study of NMDAR-related neurological diseases [1]. |
CAS Number | 2377187-09-0 |
Formula | C28H19Cl2F2N3O4 |
SMILES | O=C(O)CC(F)(F)C(=O)N1N=C(C=2C(=O)NC=3C=CC=CC3C2C=4C=CC(Cl)=CC4)CC1C5=CC=C(Cl)C=C5 |
Storage | -20°C |
Note | For research use only |